PYFAESTHETIC Successfully Holds Cadaver Training to South Korea
Jakarta, 4 April 2023 - PYFAESTHETIC, a subsidiary of PT Pyridam Farma Tbk (PYFA) engaged in the field of dermatology and aesthetics, has successfully held its third cadaver training "PYFAESTHETIC goes to Korea" by inviting 15 doctors consisting
Pyridam Farma Participates in Health Interactive Dialogue Safe Drug Syrup
Jakarta, 21 March 2023 - Pyridam Farma participated in an interactive health dialogue "Safe drug syrup" with the Association of Pharmaceutical Companies (GP Pharmacy) at the Ballroom of the Royal Kuningan Hotel Jakarta to jointly educate the Indonesian people that
Pyfaesthetic Together with Jmbiotech Presents a Range of Anti Aging Treatments for Indonesian Women
Jakarta, 29 July 2022 - Pyridam Farma Tbk (PYFA) through its subsidiary in the field of dermatology and aesthetics, PYFAESTHETIC presents The Pink - aging treatment in collaboration with JMBiotech to meet the needs of doctors for quality anti-aging products. The
Continuing to Expansion & Innovation, Pyridam Farma Officially Acquires PT Ethica Industri Pharmacy
Yenfrino Gunadi (Director of Pyridam Farma), Bedjo Stefanus (SVP of Pyridam Farma), Lee Yan Gwan (President Director of Pyridam Farma), dr Widjanarko Brotosaputro (Director of Pyridam Farma), Indrawati Taurus (Ex President Director of Ethica Pharmaceutical Industry), Susanti Haryanto (Ed Director
Pyridam Farma (PYFA) Presents an AI-Based Cervix Cancer Screening Tool, Cerviray A.I.
Jakarta, 15 July 2022 - Pyridam Farma (PYFA) together with AIDOT Inc. will soon present innovative healthcare products for the people of Indonesia, namely Cerviray A.I., a portable cervical cancer detection tool that can help women in early detection of
More Expansion! PT Pyridam Farma Tbk (PYFA) Acquisition of PT Ethica Industri Pharmaceuticals
Jakarta, 13 June 2022 - After successfully acquiring PT Holi Pharma at the end of 2021, this time PT Pyridam Farma Tbk with the issuer code PYFA again signed an agreement with companies that are part of the Fresenius Kabi
Sales of Pyridam Farma Tbk and its subsidiaries (PYFA Group) Increase 127% to Rp. 630.5 Billion in 2021
Jakarta, May 6, 2022 - PT Pyridam Farma Tbk. and its subsidiary (PYFA Group) recorded a significant increase in net sales, which increased by 127% to Rp. 630.5 Billion in 2021 compared to Rp. 277.4 billion in 2020. This increase
Mundipharma Healthcare Indonesia Appoints Pyridam Farma to Market Betadine Brand in Indonesia
Jakarta, April 5, 2022 - Mundipharma Healthcare Indonesia (MHI), the owner of the Betadine brand in Indonesia, has signed an exclusive cooperation agreement for marketing and promotion services with PT Pyridam Farma Tbk, a public pharmaceutical company in Indonesia with
Merz Therapeutics GmbH Together with Pyridam Farma Presents Innovative Products for the Indonesian Community
Jakarta, 22 March 2022 - Merz Therapeutics GmbH, an affiliate of Merz Pharmaceutical GmbH which excels in neurotoxin field with Pyridam Farma as one of the public Healthcare companies in Indonesia, announced that together they will launch an innovator product
PYFAESTHETIC Collaborates with Dongwon Medical Presenting European Standard White Rose Thread Lift
Jakarta, February 25, 2022 - After gaining success in presenting Giselligne and Aileene filler products in collaboration with CGBIO, this time PT Pyridam Farma Tbk (PYFA) through its subsidiaries in the field of dermatology and aesthetics, PYFAESTHETIC again presents a